Exposure–efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s DiseaseMaria Rosario, Irving H. Fox, Jonathan French et al.|Journal of Crohn s and Colitis|2017Cited by 161
Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s DiseaseMaria Rosario, Irving H. Fox, Jonathan French et al.|Journal of Crohn s and Colitis|2018Cited by 122
P497 Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6W. Sandborn, Irving H. Fox, Brian G. Feagan et al.|Journal of Crohn s and Colitis|2014Cited by 13
Corrigendum to “Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6” [J Crohns Colitis 8S1 (2014) P497 S274-5]William J. Sandborn, Irving H. Fox, Brian G. Feagan et al.|Journal of Crohn s and Colitis|2014Cited by 7
Reductions in Corticosteroid Use in Patients with Ulcerative Colitis or Crohnʼs Disease Treated with VedolizumabBruce E. Sands, Brian G. Feagan, Stephen B. Hanauer et al.|The American Journal of Gastroenterology|2013Cited by 6